VENCLEXTA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 14 Apr 2023)
What this means for you
Registered since 08 Nov 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86560752
- Registration number
- 5078740
- Mark type
- Stylized text
- Filed
- 11 Mar 2015
- Published for opposition
- 11 Aug 2015
- Registered
- 08 Nov 2016
- Attorney of record
- Cheryl A. Withycombe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- AbbVie Inc., North Chicago, IL, US
- AbbVie Inc., North Chicago, IL, US
- AbbVie Inc., North Chicago, IL, US
Prosecution history
- 08 Nov 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 14 Apr 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 14 Apr 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Apr 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Oct 2022 — TEAS SECTION 8 & 15 RECEIVED
- 08 Nov 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Nov 2016 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Oct 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Oct 2016 — USE AMENDMENT FILED
- 04 Oct 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Sept 2016 — TEAS STATEMENT OF USE RECEIVED
- 01 Apr 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2016 — SOU EXTENSION 1 GRANTED